Zhide Guo
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 46
- Peptidase Inhibition and Analysis 25
- Cancer Immunotherapy and Biomarkers 7
-
- Radiopharmaceutical Chemistry and Applications 35
- Medical Imaging Techniques and Applications 7
- Co-authors
- Xianzhong Zhang (82 shared papers)Rongqiang Zhuang (48 shared papers)Changrong Shi (18 shared papers)Gang Liu (5 shared papers)Nanfeng Zheng (6 shared papers)Xiaoyuan Chen (13 shared papers)Xiaohong Chen (9 shared papers)Mei Chen (2 shared papers)
- Journals
- Molecular Pharmaceutics (13 papers)Journal of Medicinal Chemistry (8 papers)European Journal of Nuclear Medicine and Molecular Imaging (7 papers)Nuclear Medicine and Biology (5 papers)Theranostics (4 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Zhide Guo
94 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 103
- Biomaterials 398
- Oncology 787
- Radiology, Nuclear Medicine and Imaging 664
- Biomedical Engineering 1.2k
- Cancer Research 256
Countries citing papers authored by Zhide Guo
This map shows the geographic impact of Zhide Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhide Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhide Guo more than expected).
Fields of papers citing papers by Zhide Guo
This network shows the impact of papers produced by Zhide Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhide Guo. The network helps show where Zhide Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhide Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 392 | |
| 2 | 2018 | 179 | |
| 3 | 2017 | 176 | |
| 4 | 2016 | 128 | |
| 5 | 2015 | 121 | |
| 6 | 2021 | 114 | |
| 7 | 2021 | 100 | |
| 8 | 2016 | 86 | |
| 9 | 2019 | 81 | |
| 10 | 2022 | 78 | |
| 11 | 2022 | 66 | |
| 12 | 2017 | 60 | |
| 13 | 2016 | 58 | |
| 14 | 2023 | 56 | |
| 15 | 2021 | 56 | |
| 16 | 2018 | 56 | |
| 17 | 2018 | 49 | |
| 18 | 2022 | 46 | |
| 19 | 2022 | 42 | |
| 20 | 2018 | 40 |
About Zhide Guo
Zhide Guo is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Biomedical Engineering and Surgery, having authored 99 papers that have together received 2.8k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (25 papers), Nanoplatforms for cancer theranostics (16 papers), Cardiac Structural Anomalies and Repair (9 papers), Protease and Inhibitor Mechanisms (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Medical Imaging Techniques and Applications (7 papers). The work is most often cited by research in Biomaterials (398 citations), Oncology (787 citations), Radiology, Nuclear Medicine and Imaging (664 citations), Biomedical Engineering (1.2k citations) and Cancer Research (256 citations). Zhide Guo has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Xianzhong Zhang, Rongqiang Zhuang, Changrong Shi, Gang Liu, Nanfeng Zheng, Xiaoyuan Chen, Xiaohong Chen, Mei Chen, Shiguang Mo and Xuejun Wen. Their work appears in journals such as Molecular Pharmaceutics, Journal of Medicinal Chemistry, European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Biology and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.